Continuing Education

The Time is Now for SGLT2 Inhibitors for Heart Failure: A Call to Overcome Clinical Inertia

November 10, 2020 Editor

Circulation: Heart Failure, Ahead of Print.

← Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
Cardiologist Evaluation of Patients with Type 2 Myocardial Infarction →